eHealth Hub: AXA's Calls for Digital Health Solution Partners
AXA is partnering with eHealth Hub and its Solution Match service to source nutrition and smoking cessation solution partners. AXA is today the number one global insurance brand, a worldwide leader in insurance and asset management operating in more than 60 countries, with 165,000 employees and agents serving 107 million clients.
Read more ...
Dr Saif Abed Talks about the WannaCry Attack
The WannaCry or WannaDecryptor virus was a world-wide phenomenon, but the NHS was badly hit. Dr Saif Abed, a founding partner of the health IT consultancy AbedGraham, says a forensic inquiry should be held into what went wrong; so the NHS can deal with the clinical and patient risk issues it exposed.
Read more ...
SERMO Unveils First Global Physician-to-Physician Drug Ratings Tool
SERMO, the largest global social network for physicians with 650,000 members worldwide, has announced the groundbreaking new "Drug Ratings" tool. Drug Ratings is the first and only global peer-to-peer prescription drug review system sourced exclusively from verified licensed physicians. With more than a quarter million ratings and 20,000 comments from doctors worldwide to date in the beta release, the Ratings platform is quickly becoming the largest global database of physician feedback on drugs.
Read more ...
Pryv Joins The Pistoia Alliance to Lower the Barriers of Adopting Innovation in Life Sciences Research and Development
As a new member at Pistoia Alliance, Pryv joins with the mission to address the growing needs for improving the adoption of innovative technologies for patient and real-world data. Positioning itself as the next industry standard for personal and real-world data standard, Pryv is looking forward to participating in the Pistoia Alliance Community to promote collaboration as many organisations would benefit significantly from industry-wide pre-competitive collaboration.
Read more ...
Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe.
Read more ...
Scopis Introduces the First Mixed-Reality Surgical Holographic Navigation Platform Integrating Microsoft HoloLens for Open and Minimally-Invasive Spine Surgery
Scopis, a company specializing in surgical navigation and medical augmented and mixed reality technologies, announced today the launch of its newest development, the Holographic Navigation Platform for use in surgery. Scopis developed this platform to offer greater precision and speed to surgeons, and better outcomes to patients undergoing open and minimally-invasive spinal procedures.
Read more ...
Devicare Raises 3 Million Euros in its Commitment to 'Remote Patient Monitoring'
Devicare, a company specializing in innovative medical devices for chronic home care patients under Remote Patient Monitoring (RPM), has closed out a seed round of 3 million euros. This funding will be used to consolidate the launch of clinical studies of two of Devicare's main product lines on the Spanish market:
Read more ...
AXA is partnering with eHealth Hub and its Solution Match service to source nutrition and smoking cessation solution partners. AXA is today the number one global insurance brand, a worldwide leader in insurance and asset management operating in more than 60 countries, with 165,000 employees and agents serving 107 million clients. 
The WannaCry or WannaDecryptor virus was a world-wide phenomenon, but the NHS was badly hit. Dr Saif Abed, a founding partner of the health IT consultancy AbedGraham, says a forensic inquiry should be held into what went wrong; so the NHS can deal with the clinical and patient risk issues it exposed. 
SERMO, the largest global social network for physicians with 650,000 members worldwide, has announced the groundbreaking new "Drug Ratings" tool. Drug Ratings is the first and only global peer-to-peer prescription drug review system sourced exclusively from verified licensed physicians. With more than a quarter million ratings and 20,000 comments from doctors worldwide to date in the beta release, the Ratings platform is quickly becoming the largest global database of physician feedback on drugs. 
As a new member at Pistoia Alliance, Pryv joins with the mission to address the growing needs for improving the adoption of innovative technologies for patient and real-world data. Positioning itself as the next industry standard for personal and real-world data standard, Pryv is looking forward to participating in the Pistoia Alliance Community to promote collaboration as many organisations would benefit significantly from industry-wide pre-competitive collaboration. 
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe. 
Scopis, a company specializing in surgical navigation and medical augmented and mixed reality technologies, announced today the launch of its newest development, the Holographic Navigation Platform for use in surgery. Scopis developed this platform to offer greater precision and speed to surgeons, and better outcomes to patients undergoing open and minimally-invasive spinal procedures. 
Devicare, a company specializing in innovative medical devices for chronic home care patients under Remote Patient Monitoring (RPM), has closed out a seed round of 3 million euros. This funding will be used to consolidate the launch of clinical studies of two of Devicare's main product lines on the Spanish market: